Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alkermes Plc (NASDAQ:ALKS)

52.16
Delayed Data
As of Dec 11
 -0.72 / -1.36%
Today’s Change
46.43
Today|||52-Week Range
63.40
-6.15%
Year-to-Date
Surging Earnings Estimates Signal Good News for Alkermes (ALKS)
Dec 07 / Zacks.com - Paid Partner Content
PRIMECAP Management Buys Micro Focus International PLC, Hewlett Packard Enterprise Co...
Dec 05 / GuruFocus News - Paid Partner Content
Primecap Management Buys Alkermes Biopharma
Dec 06 / GuruFocus News - Paid Partner Content
Biogen Acquires Worldwide License for Alkermes' MS Candidate (revised)
Nov 29 / Zacks.com - Paid Partner Content
Market-Crushing Firm Primecap Management Buys Alkermes Biopharma
Dec 06 / GuruFocus News - Paid Partner Content
Biotech Stock Roundup: Regeneron Down on Eylea Data, Biogen-Alkermes in MS Deal
Nov 29 / Zacks.com - Paid Partner Content
Market-Crushing Firm Primecap Management Buys Aklermes
Dec 05 / GuruFocus News - Paid Partner Content
Biogen Acquires Worldwide License for Alkermes' MS Candidate
Nov 28 / Zacks.com - Paid Partner Content